TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: severe postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: new venous thromboembolism
Endpoint domain: Mortality/survival
Primary endpoint: Post-operative imaging (MRI) graft incorporation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Health Belief Model Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin function/responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sweat gland function/responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum isometric voluntary contraction of knee extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: evolution of sensory-motor recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of dose-limiting toxicities (DLT's)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of overall response lasting at least 6 months (ORR6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SynKIR-110
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of SynKIR-110
Endpoint domain: Resource use
Primary endpoint: Peak power and jump height measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body coordination test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pro-agility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the Y-PATH NI Intervention to the pupils - self-report measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the Y-PATH NI Intervention to the teachers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the Y-PATH NI Intervention to parents/guardians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to First Occurrence of Any Component Event of Composite
Endpoint domain: Mortality/survival
Primary endpoint: Number and Severity of Adverse Events (AEs) Attributed to the Investigational Product, arTreg
Endpoint domain: Adverse events/effects
Primary endpoint: Number and Severity of Adverse Events (AEs) Attributed to Supportive Regimen: Leukapheresis, Cyclophosphamide or Mesna
Endpoint domain: Adverse events/effects
Primary endpoint: Target protein concentration in aqueous humor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maximum Tolerated Dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical feasibility of ultrasound-guided sciatic nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical Global Impression - Improvement (CGI-I) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Brain-derived Neurotrophic Factor (BDNF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk level of ASCVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Planned Ablations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pathological changes in the tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to therapeutic anticoagulation range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of treatment-related adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Wound-healing progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure ulcer-specific symptoms and functional outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of sobriety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dynamic knee valgus angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major congenital anomalies
Endpoint domain: Mortality/survival
Primary endpoint: Safety of the trial vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of the trial vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The newborn comfort behavior scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lowest mean blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of the intervention by participant report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the intervention by quality standards met (ultrasound)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of the intervention by quality standards met (ANC)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of the intervention by observation of functioning systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the intervention by observation of environments of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants with reported dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: peak torque of knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pain level at the patellofemoral area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip adduction peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes from baseline Ki67%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Near best corrected visual acuity on Salzburg reading desk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular hole closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Progression of brain, thalamic and cervical cord atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Geometric means ratio of Cmax of NET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric means ratio of Cmax of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric means ratio of AUC(0-T) of NET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric means ratio of AUC(0-T) of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric means ratio of AUC(INF) of NET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric means ratio of AUC(INF) of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COPD acute exacerbations rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to tamoxifen treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change on the SPEED score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nephrolithiasis recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of edematous fibrosclerotic panniculopathy measured by cellulite severity scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Skin Health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Body Surface Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Software Utilization Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of exercise repetitions completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caval aorta index for predicting hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in P100 latency of visual evoked potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Posture and posture ability scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from pain score within 48 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from agitation score within 48 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Weight Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Admission to neonatal unit
Endpoint domain: Mortality/survival
Primary endpoint: Early perinatal death
Endpoint domain: Mortality/survival
Primary endpoint: Change in Visual Acuity from baseline to 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Satisfaction from baseline to 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Cost Benefits from baseline to 6 weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of grade >= 3 non-hematologic dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute value of LDL-C reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neonatal hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sensitivity of the AI model in predicting radiochemotherapy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the AI model in predicting radiochemotherapy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall of probabilistic risk
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Presence of myocardial scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduced myocardial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pressure Biofeedback unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of amyloid positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Concentration of glycosylated hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SARS-CoV-2 S protein antibody (IgG) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing antibodies levels (true virus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing antibodies levels (pseudovirus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in glutathione
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in lipid peroxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in protein carbonyls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to onset of radiolabel release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Site of onset of radiolabel release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of TA-TMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of sC5b-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke volume persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sensitivity of diagnosing colorectal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of diagnosing colorectal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of diagnosing colorectal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand-Held Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cervico-cranial Flexion Test (Blood Pressure Cuff)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moisture control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline subjective pain via neuropathic pain symptom inventory for the eye (NPSI-eye)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline subjective pain effect experiences via Defense and Veteran Pain Rating Scale (DVPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline subjective mental symptoms via Mental Fatigue Scale (MFS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Efficacy of intraoperative analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque index (Silness & Löe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival index (Löe & Silness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of diffusion and perfusion MRI sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving 100% Reduction in Cigarettes Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative remifentanil dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Functional Independence Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Eating Assessment Tool-10
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health-Related Quality of Life Scale-KIDSCREEN-27
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Retention in HIV Care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ART Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent Knowledge Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent Education Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients who develop hospitalized bronchiectasis exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of successful Percussive Ventilation Breathhold (PVB) maneuver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of successful administration of Percussive Ventilation Breathhold Stereotactic Ablative Radiotherapy (PVB SABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: modified Hand Mobility in Scleroderma (mHAMIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of measuring Fetal Abdominal Subcutaneous Tissue Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Berry Visual Motor Integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruininks Oseretsky Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole blood viscosity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Rating Score
Endpoint domain: Life impact
Endpoint subdomain: Pain interference
Primary endpoint: Changes in tumor microenvironment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain during debridement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cultural awareness level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in social determinants knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in lumbar and thoracic scoliotic curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inspiratory delta transpulmonary pressure (stress)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Expiratory delta transpulmonary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of infants with deficient or suboptimal 25(OH)D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of therapies without wound healing disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of therapies without discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Local efficacy of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the profile of circulating micro-RNA biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cT1, PDFF and T2* levels to predict risk of developing and progression of HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the profile of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the profile of metabolome in urine and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of correct answers in the Color Comparison task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Parodontitis based on a photograph of the patient's oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parodontitis based on clinical observation of the patient's oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who experience one or more treatment-related TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: MA good rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pedi-IKDC (0-100)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Platelet to-lymphocyte ratio (PLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Canadian Cardiovascular Society (CCS) angina scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Erectile Function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Absolute change in Alzheimer's Disease Assessment Scale-Cognitive Subscale score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in weekly global gastrointestinal symptoms average index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in 24-hour urine protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Multidimensional Fatigue Inventory (MFI-20) global score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: MSWDQ-23 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of infections on emergence site
Endpoint domain: Adverse events/effects
Primary endpoint: Number of UTI events
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive Diagnoses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: AUC0-t ATI-2173, clevudine, and M1 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T1/2 ATI-2173, clevudine, and M1 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of crunching
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in numerical rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fidelity of delivery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: First occurrence of Stroke and other systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Upper Face Wrinkle Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of episodes of severe hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of episodes of Diabetic Ketoacidosis (DKA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dimensional and color assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD Negativity Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes